Avastin News and Research

RSS
Avastin is a biologic antibody designed to specifically bind to a protein called vascular endothelial growth factor (VEGF) that plays an important role throughout the lifecycle of the tumor to develop and maintain blood vessels, a process known as angiogenesis. Avastin is designed to interfere with the blood supply to a tumor by directly binding to the VEGF protein to prevent interactions with receptors on blood vessel cells. Avastin does not bind to receptors on normal or cancer cells. The tumor blood supply is thought to be critical to a tumor’s ability to grow and spread in the body (metastasize).
Genetically modified chickens could soon lay eggs containing certain medications

Genetically modified chickens could soon lay eggs containing certain medications

Hens that lay human proteins in eggs offer cost-effective method of producing new drugs

Hens that lay human proteins in eggs offer cost-effective method of producing new drugs

Global leaders in medical and surgical eye care to convene in Chicago to attend AAO 2018

Global leaders in medical and surgical eye care to convene in Chicago to attend AAO 2018

ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress

ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress

Immunotherapy medicine found to be effective in treating uveitis

Immunotherapy medicine found to be effective in treating uveitis

Chromosomal instability may predict which patients will respond better to colorectal cancer drug

Chromosomal instability may predict which patients will respond better to colorectal cancer drug

New book provides evidence that new drugs, medical technologies are safe and effective

New book provides evidence that new drugs, medical technologies are safe and effective

Saving sight of millions by making eye injections safe and comfortable

Saving sight of millions by making eye injections safe and comfortable

Scientists discover new target for anti-angiogenic tumor therapy

Scientists discover new target for anti-angiogenic tumor therapy

Largest clinical specialty database powers studies that yield key insights

Largest clinical specialty database powers studies that yield key insights

Without price breaks, rural hospitals struggle to stock costly, lifesaving drugs

Without price breaks, rural hospitals struggle to stock costly, lifesaving drugs

FDA grants approval for new biosimilar to treat multiple types of cancer

FDA grants approval for new biosimilar to treat multiple types of cancer

Two widely used drugs show effectiveness in treating patients with CRVO-associated macular edema

Two widely used drugs show effectiveness in treating patients with CRVO-associated macular edema

Molecular drug imaging likely to benefit children with brain tumors

Molecular drug imaging likely to benefit children with brain tumors

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Scottish women with metastatic carcinoma of cervix could now benefit from Avastin treatment

Scottish women with metastatic carcinoma of cervix could now benefit from Avastin treatment

NEI-funded study analyzes outcomes of anti-VEGF therapy for AMD

NEI-funded study analyzes outcomes of anti-VEGF therapy for AMD

Research unveils standard front-line treatment for advanced ovarian cancer

Research unveils standard front-line treatment for advanced ovarian cancer

Bevacizumab extends survival of pleural mesothelioma patients

Bevacizumab extends survival of pleural mesothelioma patients

New campaign raises awareness of City of Hope's life-saving mission and impact

New campaign raises awareness of City of Hope's life-saving mission and impact